• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    19.14 Down 1.40(6.82%) Jan 30, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 8,177   9,494   13,391   36,317  
    Cost of Revenue -   -   -   -  
    Gross Profit 8,177   9,494   13,391   36,317  
    Operating Expenses
    Research Development22,244  17,499  15,347  15,685  
    Selling General and Administrative5,669  5,306  4,956  4,378  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (19,736) (13,311) (6,912) 16,254  
    Income from Continuing Operations
    Total Other Income/Expenses Net41  38  28  25  
    Earnings Before Interest And Taxes(19,695)(13,273)(6,884)16,279  
    Interest Expense -   -   -   -  
    Income Before Tax(19,695)(13,273)(6,884)16,279  
    Income Tax Expense5  113   -  349  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(19,700)(13,386)(6,884)15,930  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (19,700) (13,386) (6,884) 15,930  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (19,700) (13,386) (6,884) 15,930  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.